Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
234 Leser
Artikel bewerten:
(0)

Congressman Fattah to Speak on International Neuroscience Collaboration at Swiss Embassy

Fattah will speak to regional scientists about the Fattah Neuroscience Initiative and the growing need for international brain research collaboration

WASHINGTON, Dec. 18, 2013 /PRNewswire-USNewswire/ --Congressman Chaka Fattah (PA-02) will be a featured speaker at the Embassy of Switzerland tonight in Washington where he will address a group of regional scientists on his continued efforts to elevate neuroscience as a priority within the United States, while expanding partnerships with outside countries-particularly in the European Union-to collaborate in the global struggle against brain disease. Fattah, architect of the Fattah Neuroscience Initiative, has been a leader in Congress on the issues of science and innovation.

"Tonight is a wonderful opportunity to engage with Switzerland, and further promote international cooperation towards advancing neuroscience," Congressman Fattah said. "The Swiss are some of the most visionary scientists in the world when it comes to the human brain, as evidenced by the Human Brain Project headquartered in the country. They recognize that this is a global issue and that only collectively can we make headway into better understanding the brain."

Ambassador Manuel Sager, hosting the event, stressed the value of international scientific collaboration in the 21st century. "Especially on a topic as ambitious as both the Brain Initiative and the Human Brain Project, we need to join forces whenever possible. And these two projects present an especially unique opportunity to pool our research across the Atlantic," he said. Referring to a recent study by the US-Israel Science & Technology Foundation (USISTF) according to which Switzerland is the U.S.'s most important innovation partner, he added: "I am very pleased that the brain projects will deepen the scientific relationship between our two countries even further." His Excellency expressed his gratitude of having Congressman Fattah to speak in favor of such a cooperation shaping today's research landscape.

Tonight, Fattah will also announce his efforts to create an enhanced database of brain diseases, allowing researchers worldwide to have easier access to the most current research and clinical trial data. The database will closely model the International Alzheimer's Disease Research Portfolio (IADRP) developed by the National Institutes of Health. Fattah has been pushing for increased international collaboration between the White House Office of Science and Technology Policy (OSTP) and other countries who are leaders in neuroscience research and technology, like Switzerland.

Joining Fattah as a speaker this evening is Noah Hutton, a film director who is currently working on a 10-part documentary on the Human Brain Project, headquartered in Lausanne, Switzerland. Hutton said he is excited to be able to present the trailer of his documentary series to Congressman Fattah, an involved audience in Washington, D.C., and as a guest of Ambassador Sager.

Through the Fattah Neuroscience Initiative, Fattah has spent the last two years advocating across the globe for increased funding, support, and partnership around brain research. Earlier this week, he joined Rep. Steve Israel and five organizations, including Israel Brain Technologies, to formalize a historic partnership in neuroscience research.

SOURCE Office of Congressman Chaka Fattah

© 2013 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.